We are live on ! Find out more
IHM

Iguana Healthcare Management Portfolio holdings

AUM $152M
1-Year Est. Return 48.74%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
+48.74%
3 Year Est. Return
+142.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$214M
AUM Growth
-$1.94M
Cap. Flow
-$12M
Cap. Flow %
-5.58%
Top 10 Hldgs %
39.29%
Holding
99
New
24
Increased
11
Reduced
21
Closed
34

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.98M
2
ABBV icon
AbbVie
ABBV
+$4.46M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$4.25M
4
HCA icon
HCA Healthcare
HCA
+$4.22M
5
THC icon
Tenet Healthcare
THC
+$3.84M

Top Sells

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$8.04M
2
CI icon
Cigna
CI
+$6.22M
3
MRK icon
Merck
MRK
+$3.29M
4
PFE icon
Pfizer
PFE
+$3.21M
5
INCY icon
Incyte
INCY
+$3.08M

Sector Composition

Rank Sector Weight
1 Healthcare 67.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
1
Biogen
BIIB
$30B
$12M 5.59%
38,000
-6,000
-14% -$1.81M
AMGN icon
2
Amgen
AMGN
$208B
$9.77M 4.56%
82,500
-21,500
-21% -$2.49M
AMGN icon
3
PUT
Amgen
AMGN
$208B
$9.77M 4.56%
82,500
-17,500
-18% -$2.03M
MDT icon
4
Medtronic
MDT
$109B
$9.72M 4.54%
152,500
+42,500
+39% +$2.58M
CELG
5
DELISTED
Celgene Corp
CELG
$9.02M 4.21%
+105,000
New +$7.98M
OEF icon
6
PUT
iShares S&P 100 ETF
OEF
$20.1B
$8.91M 4.16%
+75,000
New +$6.33M
MRK icon
7
Merck
MRK
$322B
$8.53M 3.98%
154,580
-60,260
-28% -$3.29M
GILD icon
8
Gilead Sciences
GILD
$162B
$6.22M 2.9%
75,000
+25,000
+50% +$1.95M
VTRS icon
9
Viatris
VTRS
$20.4B
$5.41M 2.53%
105,000
-7,500
-7% -$369K
SPY icon
10
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$4.89M 2.28%
+25,000
New +$4.75M
ABBV icon
11
AbbVie
ABBV
$443B
$4.8M 2.24%
+85,000
New +$4.46M
IONS icon
12
Ionis Pharmaceuticals
IONS
$8.6B
$4.65M 2.17%
+135,000
New +$4.25M
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.56M 2.13%
42,500
+17,500
+70% +$1.22M
HCA icon
14
HCA Healthcare
HCA
$87.2B
$4.51M 2.1%
+80,000
New +$4.22M
PRGO icon
15
CALL
Perrigo
PRGO
$1.4B
$4.37M 2.04%
+30,000
New +$4.25M
CELG
16
PUT
DELISTED
Celgene Corp
CELG
$4.29M 2%
+50,000
New +$3.8M
ALKS icon
17
Alkermes
ALKS
$8.22B
$4.28M 2%
85,000
-15,000
-15% -$692K
SUPN icon
18
Supernus Pharmaceuticals
SUPN
$2.59B
$4.11M 1.92%
375,000
+275,000
+275% +$2.45M
HZNP
19
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.04M 1.88%
255,000
-65,000
-20% -$928K
THC icon
20
Tenet Healthcare
THC
$20.5B
$3.99M 1.86%
+85,000
New +$3.84M
ALXN
21
DELISTED
Alexion Pharmaceuticals
ALXN
$3.91M 1.82%
25,000
+5,000
+25% +$789K
XLRN
22
DELISTED
Acceleron Pharma
XLRN
$3.74M 1.74%
+110,000
New +$3.68M
STJ
23
DELISTED
St Jude Medical
STJ
$3.64M 1.7%
+52,500
New +$3.4M
AERI
24
DELISTED
Aerie Pharmaceuticals
AERI
$3.61M 1.68%
145,700
-64,300
-31% -$1.11M
CLDX icon
25
Celldex Therapeutics
CLDX
$2.99B
$3.43M 1.6%
14,000
-333
-2% -$75.2K
1
2 3 4

Similar funds

HWP
Hefty Wealth Partners Auburn, Indiana $155M AUM 7.56% 1-Year Est. Return
PAM
PineView Asset Management Greenwich, Connecticut $166M AUM 27.74% 1-Year Est. Return
USG2
Union Square GP 2008 New York $172M AUM
LCM
Lee Capital Management New York $132M AUM 21% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
FIAS
FinTrust Investment Advisory Services Greenville, South Carolina $109M AUM
CII
Chapter IV Investors Charlotte, North Carolina $109M AUM 9.21% 1-Year Est. Return
OPWM
Oak Point Wealth Management Portage, Michigan $98M AUM

Iguana Healthcare Management's Q2 2014 Portfolio in Review

As of Q2 2014, Iguana Healthcare Management held 99 positions worth $214M, down 0.89% from $216M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Iguana Healthcare Management withdrew a net $12M in Q2 2014, closing 34 positions and reducing 21 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.04M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 65% a quarter earlier.

Against the trend, Iguana Healthcare Management opened a new position in Celgene Corp worth $9.02M.

  • Iguana Healthcare Management's largest Q2 2014 buy was Celgene Corp: 105,000 shares worth $9.02M.
  • Iguana Healthcare Management added most to Medtronic in Q2 2014, an estimated $2.58M increase.
  • Iguana Healthcare Management's biggest Q2 2014 reduction was Cigna, cutting an estimated $6.22M.
  • Iguana Healthcare Management fully exited Zimmer Biomet in Q2 2014, selling an estimated $8.04M.
  • Iguana Healthcare Management's ten largest holdings make up 39% of its $214M portfolio in Q2 2014.
  • Iguana Healthcare Management opened 24 new positions and closed 34 in Q2 2014.
  • Iguana Healthcare Management's portfolio value fell 0.89% quarter-over-quarter to $214M.

Based on Iguana Healthcare Management's 13F filing for Q2 2014, filed 14 Aug 2014.